Our drug discovery system seems broken: Richard Owens in the Financial Post
Now more than ever, we should want drug companies to be able to charge high prices, writes Richard Owens in the Financial Post. Below...
The court backs creators, not universities: Richard Owens in the Financial Post
Universities have relied on 'fair dealing' provisions to photocopy mountains of material and distribute them to students, writes Richard Owens. By Richard Owens,...
Google should start playing nice with the news media: Richard Owens in The National Post
The internet is far better off with authoritative, factual sources of reference, such as are provided by professional, fact-checking newspapers. Google’s news service...
Econ 101: Drug price controls shrink supply: Richard Owens in the Financial Post
Increased drug revenues enable increased research and development expenditures, which in turn result in better health and longer lives, writes Richard Owens. By...
A better innovation policy: Protect ideas, don’t subsidize businesses: Richard Owens and Brett Byers in the Financial Post
Current innovation policies are a mess of disparate and expensive programs that dole out vast amounts of money wastefully and inefficiently, write Richard Owens...
2019 may have been a new dawn for hope and revolution: Richard Owens in the Financial Post
On a grander scale there is much to be grateful for from 2019. Hope and revolution are in the air, writes Richard Owens. ...
In GoldTV, internet activism runs aground. Again: Richard Owens in the Financial Post
GoldTV is one of a species of IP thieves that take advantage of the internet’s anonymity and reach, writes Richard Owens. By Richard...
Real innovation required: Richard Owens in the Hill Times
We need a whole new direction on innovation. Let’s wind up all the innovation corporate welfare programs and return their budget allocations to...
A real innovation agenda for Canada: MLI Commentary by Richard Owens
OTTAWA, ON (October 11, 2019): Canada lags behind other developed nations when it comes to innovation. From declining investments in research and development...
Canada’s New Rules Aiming to Cut Drug Prices May Penalize Consumers: Richard Owens in the Epoch Times
Price-focused regulatory changes could limit access to new drugs and dampen R&D investment, writes Richard Owens. By Richard C. Owens, September 17, 2019...
